Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P D Greenberg

Showing results (61-70 of 153) with videos related to

Pageof 16
Sort By:
Proceedings of the National Academy of Sciences of the United States of America|March 4, 1997
Requirement for an initial signal from the membrane-proximal region of the interleukin 2 receptor gamma(c) chain for Janus kinase activation leading to T cell proliferationB H Nelson, B C McIntosh, L L Rosencrans, et al.
Bone Marrow Transplantation|January 1, 1994
Selective reconstitution of CD8+ cytotoxic T lymphocyte responses in immunodeficient bone marrow transplant recipients by the adoptive transfer of T cell clonesS R Riddell, B A Walter, M J Gilbert, et al.
Journal of Immunology (Baltimore, Md. : 1950)|June 1, 1986
Requirement for recognition of class II molecules and processed tumor antigen for optimal generation of syngeneic tumor-specific class I-restricted CTLD E Kern, J P Klarnet, M C Jensen, et al.
Immunobiology|September 1, 1986
Potential uses of interleukin 2 in cancer therapyM A Cheever, J A Thompson, D J Peace, et al.
AIDS Research and Human Retroviruses|May 1, 1994
HIV-infected macrophages as efficient stimulator cells for detection of cytotoxic T cell responses to HIV in seronegative and seropositive vaccine recipientsM J McElrath, M Hoffman, S Kluckling, et al.
Cancer Research|October 1, 1990
Requirements for the generation of a Lyt-2+ T-cell proliferative response to a syngeneic tumor in the absence of L3T4+ T-cellsD E Kern, J P Klarnet, M A Cheever, et al.
Journal of Immunology (Baltimore, Md. : 1950)|February 29, 2000
The IL-2 receptor promotes lymphocyte proliferation and induction of the c-myc, bcl-2, and bcl-x genes through the trans-activation domain of Stat5J D Lord, B C McIntosh, P D Greenberg, et al.
Journal of Virology|June 1, 1993
Selective interference with class I major histocompatibility complex presentation of the major immediate-early protein following infection with human cytomegalovirusM J Gilbert, S R Riddell, C R Li, et al.
Journal of Immunology (Baltimore, Md. : 1950)|October 30, 1998
The IL-2 receptor promotes proliferation, bcl-2 and bcl-x induction, but not cell viability through the adapter molecule ShcJ D Lord, B C McIntosh, P D Greenberg, et al.
Progress in Experimental Tumor Research|January 1, 1988
Therapy of disseminated tumors by adoptive transfer of specifically immune T cellsP D Greenberg, J P Klarnet, D E Kern, et al.
Pageof 16

Showing results (61-70 of 153) with videos related to

Sort By:
Pageof 16
Proceedings of the National Academy of Sciences of the United States of America|March 4, 1997
Requirement for an initial signal from the membrane-proximal region of the interleukin 2 receptor gamma(c) chain for Janus kinase activation leading to T cell proliferationB H Nelson, B C McIntosh, L L Rosencrans, et al.
Bone Marrow Transplantation|January 1, 1994
Selective reconstitution of CD8+ cytotoxic T lymphocyte responses in immunodeficient bone marrow transplant recipients by the adoptive transfer of T cell clonesS R Riddell, B A Walter, M J Gilbert, et al.
Journal of Immunology (Baltimore, Md. : 1950)|June 1, 1986
Requirement for recognition of class II molecules and processed tumor antigen for optimal generation of syngeneic tumor-specific class I-restricted CTLD E Kern, J P Klarnet, M C Jensen, et al.
Immunobiology|September 1, 1986
Potential uses of interleukin 2 in cancer therapyM A Cheever, J A Thompson, D J Peace, et al.
AIDS Research and Human Retroviruses|May 1, 1994
HIV-infected macrophages as efficient stimulator cells for detection of cytotoxic T cell responses to HIV in seronegative and seropositive vaccine recipientsM J McElrath, M Hoffman, S Kluckling, et al.
Cancer Research|October 1, 1990
Requirements for the generation of a Lyt-2+ T-cell proliferative response to a syngeneic tumor in the absence of L3T4+ T-cellsD E Kern, J P Klarnet, M A Cheever, et al.
Journal of Immunology (Baltimore, Md. : 1950)|February 29, 2000
The IL-2 receptor promotes lymphocyte proliferation and induction of the c-myc, bcl-2, and bcl-x genes through the trans-activation domain of Stat5J D Lord, B C McIntosh, P D Greenberg, et al.
Journal of Virology|June 1, 1993
Selective interference with class I major histocompatibility complex presentation of the major immediate-early protein following infection with human cytomegalovirusM J Gilbert, S R Riddell, C R Li, et al.
Journal of Immunology (Baltimore, Md. : 1950)|October 30, 1998
The IL-2 receptor promotes proliferation, bcl-2 and bcl-x induction, but not cell viability through the adapter molecule ShcJ D Lord, B C McIntosh, P D Greenberg, et al.
Progress in Experimental Tumor Research|January 1, 1988
Therapy of disseminated tumors by adoptive transfer of specifically immune T cellsP D Greenberg, J P Klarnet, D E Kern, et al.
Pageof 16